To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANKRD27TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
237 supporting clones for gene ANKRD27 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA725301 parathyroid gland, parathyroid tumor ANKRD27.a 4064 to 4456 410 to 18       393/410
(95 %)
0 diff
(100 %id)
AA781169   ANKRD27.a 3074 to 3547 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
AA326035 brain, cerebellum ANKRD27.a 30 to 371 1 to 345       345/345
(100 %)
7 diff
(98.0 %id)
AA332195 Embryo, 8 weeks ANKRD27.a 3166 to 3502 10 to 345       336/345
(97 %)
6 diff
(98.3 %id)
AA380955   ANKRD27.a 3613 to 3969 13 to 369       357/374
(95 %)
6 diff
(98.4 %id)
AF447882   ANKRD27.c 1 to 3304 1 to 3307 H160L R161I T162E F163H R164S ... tiling clone, AAA   3307/3307
(100 %)
15 diff
(99.6 %id)
AK054561 Spleen ANKRD27.a 21 to 4455 1 to 4435 exact tiling clone, available from FLJ,   4435/4435
(100 %)
0 diff
(100 %id)
AL136784 testis ANKRD27.a 33 to 4455 1 to 4423 S657G P761R available from DKFZ, AAA   4423/4423
(100 %)
4 diff
(100.0 %id)
AL834335 testis ANKRD27.a 2093 to 4455 1 to 2363   available from DKFZ, AAA   2363/2363
(100 %)
3 diff
(99.9 %id)
AW361408 colon ANKRD27.a 3572 to 3835 1 to 263       263/263
(100 %)
6 diff
(97.8 %id)
AW578509 colon ANKRD27.a 3367 to 3897 1 to 531       531/531
(100 %)
3 diff
(99.5 %id)
AW578518 colon ANKRD27.a 3366 to 3897 1 to 532       532/532
(100 %)
8 diff
(98.5 %id)
AW838828 leiomios ANKRD27.a 2274 to 2609 1 to 336       336/344
(97 %)
9 diff
(97.4 %id)
AW838831 leiomios ANKRD27.a 2261 to 2609 11 to 360       350/368
(95 %)
8 diff
(97.9 %id)
AW864260 stomach_normal ANKRD27.a 3931 to 4357 25 to 454       430/465
(92 %)
10 diff
(97.9 %id)
AW880859 ovary ANKRD27.g 1 to 443 1 to 443 L3F tiling clone,   443/444
(99 %)
3 diff
(99.4 %id)
AW880876 ovary ANKRD27.g 10 to 559 1 to 549 exact tiling clone,   549/549
(100 %)
4 diff
(99.3 %id)
AW881140 ovary ANKRD27.g 346 to 818 489 to 17   tiling clone,   473/489
(96 %)
0 diff
(100 %id)
AW960214   ANKRD27.a 3613 to 4245 24 to 653       630/655
(96 %)
16 diff
(97.6 %id)
BC050529 Testis, embryonal carcinoma ANKRD27.a 54 to 4455 1 to 4400 exact available from MGC, AAA   4400/4400
(100 %)
7 diff
(99.9 %id)
BE174131 head_neck ANKRD27.a 3088 to 3320 10 to 242       233/244
(95 %)
6 diff
(97.6 %id)
BE840967 stomach_normal ANKRD27.a 3562 to 4107 6 to 551       546/551
(99 %)
6 diff
(99.0 %id)
BE927206 colon ANKRD27.a 3366 to 3897 21 to 553       533/553
(96 %)
6 diff
(99.0 %id)
BF094073 uterus_tumor ANKRD27.a 31 to 323 16 to 308       293/312
(93 %)
8 diff
(97.5 %id)
BF336040 colon ANKRD27.c 3188 to 3524 14 to 350   tiling clone,   337/357
(94 %)
9 diff
(97.5 %id)
BF798317 colon_ins ANKRD27.a 235 to 610 1 to 375       375/385
(97 %)
7 diff
(98.2 %id)
BF882684 lung_tumor ANKRD27.h 205 to 765 561 to 1   tiling clone, Submitted on the opposite strand 561/561
(100 %)
0 diff
(100 %id)
BF916733 uterus_tumor ANKRD27.j-u 1 to 246 1 to 250 S4G Q7R E8K E21R E22G ... tiling clone,   250/250
(100 %)
15 diff
(94.0 %id)
BF925717 nervous_tumor ANKRD27.h 95 to 447 362 to 10     Submitted on the opposite strand 353/362
(97 %)
1 diff
(99.8 %id)
BF991869 placenta_normal ANKRD27.a 343 to 790 79 to 527       449/527
(85 %)
6 diff
(98.9 %id)
BG989407 head_neck ANKRD27.a 1430 to 1831 18 to 419       402/419
(95 %)
18 diff
(95.8 %id)
BQ324700 colon_ins ANKRD27.a 2243 to 2718 1 to 476       476/476
(100 %)
5 diff
(99.0 %id)
BX107480 multiple sclerosis lesions ANKRD27.a 3710 to 4064 1 to 355       355/356
(99 %)
3 diff
(99.2 %id)
F02388 brain, total brain ANKRD27.a 4275 to 4456 182 to 1       182/182
(100 %)
4 diff
(97.9 %id)
F02410 brain, total brain ANKRD27.a 4226 to 4456 229 to 1       229/229
(100 %)
5 diff
(97.9 %id)
F04890 brain, total brain ANKRD27.e 1593 to 1760 164 to 1   tiling clone,   164/180
(91 %)
6 diff
(96.7 %id)
Z44125 brain, total brain ANKRD27.e 166 to 460 35 to 329   tiling clone,   295/329
(89 %)
7 diff
(97.9 %id)
AV739976 cord Blood ANKRD27.a 2470 to 2887 46 to 451       406/469
(86 %)
15 diff
(96.9 %id)
CD687453 normal nasopharynx ANKRD27.a 3234 to 3540 21 to 326       306/326
(93 %)
6 diff
(98.2 %id)
CN262162 embryonic stem cells, DMSO-treated H9 cellline ANKRD27.a 45 to 665 1 to 622       622/622
(100 %)
3 diff
(99.6 %id)
CN262163 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ANKRD27.a 3120 to 3696 1 to 577       577/577
(100 %)
5 diff
(99.2 %id)
CN262164 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ANKRD27.a 3761 to 4450 1 to 690       690/690
(100 %)
0 diff
(100 %id)
CN262165 embryonic stem cells, cell lines H1, H7, andH9 ANKRD27.a 3780 to 4305 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
CN262166 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells ANKRD27.a 1853 to 2540 1 to 691       691/693
(99 %)
7 diff
(99.0 %id)
CN262167 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells ANKRD27.d 705 to 1334 1 to 630   tiling clone,   630/630
(100 %)
3 diff
(99.6 %id)
CN262168 embryonic stem cells, cell lines H1, H7, andH9 ANKRD27.a 277 to 383 1 to 107       107/107
(100 %)
0 diff
(100 %id)
CN262169 embryonic stem cells, DMSO-treated H9 cellline ANKRD27.a 38 to 393 126 to 481       356/481
(74 %)
6 diff
(98.8 %id)
BX331986 Neuroblastoma Cot 25-normalized ANKRD27.a 64 to 898 1 to 834       834/834
(100 %)
13 diff
(98.5 %id)
BX372622 Neuroblastoma Cot 25-normalized ANKRD27.a 3555 to 4454 892 to 4       889/896
(99 %)
0 diff
(100 %id)
BX332355 Neuroblastoma Cot 25-normalized ANKRD27.a 3442 to 4019 950 to 387       564/1020
(55 %)
0 diff
(100 %id)
AL529484 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized ANKRD27.a 3354 to 4435 1070 to 1       1070/1149
(93 %)
15 diff
(98.7 %id)
AL529485 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized ANKRD27.a 668 to 1699 18 to 1035       1018/1035
(98 %)
22 diff
(97.9 %id)
AL536944 brain, fetal brain ANKRD27.a 70 to 1149 1 to 1077       1077/1077
(100 %)
8 diff
(99.3 %id)
AL566578 brain, fetal brain ANKRD27.a 3562 to 4355 867 to 73       795/1030
(77 %)
0 diff
(100 %id)
BX352309   ANKRD27.a 3662 to 4448 794 to 1       794/897
(88 %)
46 diff
(94.9 %id)
BX362216   ANKRD27.a 1257 to 1699 1 to 443       443/647
(68 %)
8 diff
(98.8 %id)
BX370340   ANKRD27.a 1574 to 2467 1 to 892       890/892
(99 %)
11 diff
(98.8 %id)
BX646166   ANKRD27.c 1743 to 2213 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
EL734618 mixed ANKRD27.a 166 to 742 1 to 577       577/577
(100 %)
16 diff
(97.3 %id)
DA482249   ANKRD27.a 58 to 647 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
ES312374 frontal balding hair, skin ANKRD27.a 2790 to 2957 1 to 167       167/167
(100 %)
6 diff
(96.5 %id)
ES314249 occipital scalp hair, skin ANKRD27.a 1410 to 1535 1 to 128       128/128
(100 %)
2 diff
(98.5 %id)
FN098288 breast carcinoma ANKRD27.a 4296 to 4412 1 to 119       119/119
(100 %)
3 diff
(97.5 %id)
AV695193 hepatocellular carcinoma ANKRD27.a 3456 to 3834 1 to 375       375/386
(97 %)
6 diff
(98.5 %id)
AV697390 hepatocellular carcinoma ANKRD27.a 3456 to 3834 1 to 375       375/386
(97 %)
3 diff
(99.3 %id)
DB453005 testis ANKRD27.a 42 to 531 1 to 490       490/490
(100 %)
0 diff
(100 %id)
DB518480 testis ANKRD27.a 3130 to 3563 1 to 434     Submitted on the opposite strand 434/435
(99 %)
3 diff
(99.4 %id)
DB461929 testis ANKRD27.d 1 to 482 1 to 482   tiling clone,   482/482
(100 %)
1 diff
(99.8 %id)
DB527349 testis ANKRD27.a 3972 to 4453 1 to 482     Submitted on the opposite strand 482/483
(99 %)
1 diff
(99.8 %id)
R40254 whole brain ANKRD27.a 4230 to 4457 235 to 8       228/235
(97 %)
0 diff
(100 %id)
R14813 whole brain ANKRD27.a 3047 to 3462 1 to 421       421/487
(86 %)
17 diff
(96.6 %id)
T77529 liver and spleen ANKRD27.a 4166 to 4457 293 to 3       291/293
(99 %)
0 diff
(100 %id)
T77565 liver and spleen ANKRD27.a 3164 to 3525 1 to 368       368/376
(97 %)
19 diff
(95.0 %id)
N31817 melanocyte ANKRD27.a 3904 to 4455 560 to 1       560/560
(100 %)
16 diff
(97.2 %id)
N42486 melanocyte ANKRD27.a 3028 to 3473 1 to 451       451/456
(98 %)
16 diff
(96.5 %id)
N45989 multiple sclerosis lesions ANKRD27.a 3723 to 4106 1 to 390   fully sequenced,   390/390
(100 %)
2 diff
(99.5 %id)
N45990 multiple sclerosis lesions ANKRD27.a 4076 to 4462 390 to 1   fully sequenced,   390/390
(100 %)
7 diff
(98.3 %id)
W49710 senescent fibroblast ANKRD27.a 3485 to 3991 1 to 518       518/519
(99 %)
13 diff
(97.5 %id)
W49711 senescent fibroblast ANKRD27.a 3992 to 4455 493 to 22   AAA   472/474
(99 %)
10 diff
(97.9 %id)
AA010064 heart ANKRD27.a 3971 to 4457 486 to 1       486/488
(99 %)
7 diff
(98.6 %id)
AA026027 heart ANKRD27.a 3862 to 4290 1 to 433       433/473
(91 %)
8 diff
(98.4 %id)
AA708648 heart ANKRD27.a 4239 to 4458 222 to 2       221/222
(99 %)
0 diff
(100 %id)
W90050.
matches multiple genes
liver and spleen ANKRD27.a 3546 to 4011 1 to 466     also hits gene morwey 466/466
(100 %)
1 diff
(99.8 %id)
W90006 liver and spleen ANKRD27.a 4348 to 4447 100 to 1       100/105
(95 %)
0 diff
(100 %id)
AA132655 colon, tumor ANKRD27.a 4028 to 4455 432 to 2       431/434
(99 %)
0 diff
(100 %id)
AA132827 colon, tumor ANKRD27.a 1911 to 2313 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
AA143101 Pancreas ANKRD27.a 1272 to 1687 1 to 417       417/418
(99 %)
3 diff
(99.3 %id)
AA150390 Pancreas ANKRD27.a 3985 to 4455 471 to 2       470/471
(99 %)
0 diff
(100 %id)
AA218700 brain, neuroepithelial cells ANKRD27.a 886 to 1271 1 to 386       386/386
(100 %)
0 diff
(100 %id)
AA218701 brain, neuroepithelial cells ANKRD27.a 4066 to 4456 403 to 13   AAA   391/391
(100 %)
0 diff
(100 %id)
AA283796 ovarian tumor, ovary ANKRD27.a 4058 to 4462 406 to 2       405/406
(99 %)
0 diff
(100 %id)
AA290903 ovarian tumor, ovary ANKRD27.a 3185 to 3533 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
AA477738 ovarian tumor, ovary ANKRD27.a 4325 to 4462 139 to 2       138/139
(99 %)
0 diff
(100 %id)
AA477843 ovarian tumor, ovary ANKRD27.a 3163 to 3682 11 to 527       517/527
(98 %)
6 diff
(98.9 %id)
AA437140   ANKRD27.a 4130 to 4454 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
AA426602 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ANKRD27.a 3475 to 3955 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
AA565878 colon, tumor ANKRD27.a 4167 to 4457 296 to 6       291/296
(98 %)
0 diff
(100 %id)
AA635541 normal prostate, Prostate ANKRD27.a 4041 to 4307 267 to 1       267/267
(100 %)
0 diff
(100 %id)
AA768204 germinal center B cell ANKRD27.a 4267 to 4458 222 to 31   AAA   192/203
(94 %)
4 diff
(98.1 %id)
AA830091 germinal center B cell ANKRD27.a 4051 to 4455 426 to 22   AAA   405/405
(100 %)
1 diff
(99.8 %id)
AA835770 germinal center B cell ANKRD27.a 4121 to 4446 356 to 31   AAA   326/326
(100 %)
0 diff
(100 %id)
AA861565   ANKRD27.a 4050 to 4447 403 to 6       398/403
(98 %)
0 diff
(100 %id)
AA903176 leiomyosarcoma, soft tissue ANKRD27.a 4064 to 4462 405 to 9       397/405
(98 %)
0 diff
(100 %id)
AI052548   ANKRD27.a 3944 to 4455 519 to 8       512/519
(98 %)
0 diff
(100 %id)
AI187159 lung ANKRD27.a 4041 to 4455 414 to 2       413/414
(99 %)
0 diff
(100 %id)
AI275871 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ANKRD27.a 4061 to 4455 415 to 21   AAA   395/395
(100 %)
2 diff
(99.5 %id)
AI523755 B-cell, chronic lymphotic leukemia ANKRD27.a 4090 to 4455 410 to 45   AAA   366/366
(100 %)
28 diff
(92.4 %id)
AI619592 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ANKRD27.a 4169 to 4455 290 to 4       287/290
(98 %)
0 diff
(100 %id)
AI936638 pooled ANKRD27.a 3957 to 4455 502 to 4       499/502
(99 %)
0 diff
(100 %id)
AW054943 adenocarcinoma, Pancreas ANKRD27.a 4021 to 4458 436 to 1       436/436
(100 %)
5 diff
(98.9 %id)
AI951422 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary ANKRD27.a 3932 to 4455 533 to 12   AAA   522/522
(100 %)
6 diff
(98.9 %id)
AW087547 pooled ANKRD27.a 4017 to 4454 439 to 1       439/441
(99 %)
9 diff
(98.0 %id)
AW104563 pooled ANKRD27.a 4035 to 4455 426 to 6       421/426
(98 %)
0 diff
(100 %id)
AW152436 serous papillary carcinoma, high grade, 2pooled tumors, uterus ANKRD27.a 3953 to 4458 504 to 1       504/504
(100 %)
6 diff
(98.9 %id)
AW242266 adenocarcinoma, Pancreas ANKRD27.a 4101 to 4455 358 to 5       354/358
(98 %)
0 diff
(100 %id)
AW204312   ANKRD27.a 4099 to 4456 375 to 18   AAA   358/358
(100 %)
9 diff
(97.5 %id)
AW276283 lung, two pooled squamous cell carcinomas ANKRD27.a 4088 to 4457 378 to 9       370/378
(97 %)
0 diff
(100 %id)
AW161366 brain, frontal lobe ANKRD27.e 1 to 439 1 to 439   tiling clone,   439/439
(100 %)
0 diff
(100 %id)
AW161822 brain, frontal lobe ANKRD27.e 1415 to 1760 380 to 37   tiling clone,   344/380
(90 %)
0 diff
(100 %id)
AW473345 serous papillary carcinoma, high grade, 2pooled tumors, uterus ANKRD27.a 4064 to 4458 393 to 1       393/393
(100 %)
5 diff
(98.8 %id)
AW402254 lymph ANKRD27.a 2933 to 3416 9 to 492       485/492
(98 %)
11 diff
(97.8 %id)
AW402283 lymph ANKRD27.a 2933 to 3289 9 to 366       359/366
(98 %)
10 diff
(97.3 %id)
BU428531 lymph ANKRD27.a 202 to 750 1 to 549       549/550
(99 %)
5 diff
(99.1 %id)
BU429450 lymph ANKRD27.a 59 to 241 8 to 190       183/191
(95 %)
8 diff
(95.9 %id)
BU429457 lymph ANKRD27.a 1653 to 1922 1 to 271       271/283
(95 %)
12 diff
(95.8 %id)
BU429349 lymph ANKRD27.a 1156 to 1720 1 to 565       565/565
(100 %)
5 diff
(99.2 %id)
BU431421 lymph ANKRD27.a 202 to 603 1 to 402       402/402
(100 %)
5 diff
(98.8 %id)
AW502284 lymph ANKRD27.a 179 to 642 1 to 464       464/464
(100 %)
5 diff
(99.0 %id)
AW502444 lymph ANKRD27.a 179 to 723 1 to 545       545/545
(100 %)
6 diff
(98.9 %id)
AW499871 lymph ANKRD27.a 607 to 1140 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
AW499884 lymph ANKRD27.a 607 to 1134 1 to 528       528/528
(100 %)
3 diff
(99.5 %id)
AW500543 lymph ANKRD27.a 69 to 532 8 to 471       464/471
(98 %)
7 diff
(98.6 %id)
AW576313 lymph ANKRD27.a 4052 to 4455 421 to 18   AAA   404/404
(100 %)
2 diff
(99.6 %id)
AW500707 lymph ANKRD27.b 1 to 557 1 to 557   tiling clone,   557/557
(100 %)
5 diff
(99.2 %id)
AW576340 lymph ANKRD27.b 4027 to 4394 386 to 19   tiling clone, AAA   368/368
(100 %)
1 diff
(99.8 %id)
AW505022 lymph ANKRD27.a 67 to 240 1 to 174       174/174
(100 %)
6 diff
(96.6 %id)
AW576546 lymph ANKRD27.a 4111 to 4456 365 to 20       346/365
(94 %)
0 diff
(100 %id)
CF137262 lymph ANKRD27.a 1156 to 1558 1 to 403       403/405
(99 %)
21 diff
(94.9 %id)
CF136623 lymph ANKRD27.a 47 to 503 1 to 457       457/457
(100 %)
5 diff
(99.0 %id)
CF142209 lymph ANKRD27.a 179 to 394 1 to 216       216/216
(100 %)
11 diff
(95.0 %id)
CF143181 lymph ANKRD27.a 179 to 535 1 to 357       357/371
(96 %)
7 diff
(98.2 %id)
CF142897 lymph ANKRD27.a 179 to 515 1 to 337       337/337
(100 %)
6 diff
(98.3 %id)
BE547907 cervical carcinoma cell line, cervix ANKRD27.a 2616 to 3400 1 to 782       782/787
(99 %)
30 diff
(96.2 %id)
BE392372 endometrium, adenocarcinoma cell line, uterus ANKRD27.a 2165 to 2800 1 to 637       637/638
(99 %)
6 diff
(99.1 %id)
BE392452 endometrium, adenocarcinoma cell line, uterus ANKRD27.a 2827 to 3495 1 to 675       675/726
(92 %)
17 diff
(97.7 %id)
BC015552 Colon, adenocarcinoma ANKRD27.a 2444 to 4456 1 to 2011   available from MGC, AAA   2011/2011
(100 %)
9 diff
(99.6 %id)
BE869042 adenocarcinoma, colon ANKRD27.a 2463 to 3247 1 to 785   available from MGC,   785/1108
(70 %)
39 diff
(96.5 %id)
BE884160 leiomyosarcoma, uterus ANKRD27.a 3553 to 4294 1 to 738       738/879
(83 %)
26 diff
(97.1 %id)
BE883112 leiomyosarcoma, uterus ANKRD27.a 1840 to 2544 1 to 698       698/1078
(64 %)
21 diff
(98.1 %id)
BE889890 leiomyosarcoma, uterus ANKRD27.a 3007 to 3730 1 to 713       713/942
(75 %)
24 diff
(97.5 %id)
BE746654 adenocarcinoma cell line, ovary ANKRD27.a 2886 to 3555 1 to 669       669/670
(99 %)
7 diff
(99.0 %id)
BE746951 adenocarcinoma cell line, ovary ANKRD27.a 2998 to 3805 1 to 811       811/911
(89 %)
17 diff
(98.2 %id)
BF683280 leiomyosarcoma cell line, uterus ANKRD27.a 3304 to 4099 1 to 784       784/894
(87 %)
39 diff
(95.7 %id)
BG258623 embryonal carcinoma, cell line, testis ANKRD27.a 78 to 747 1 to 664       664/844
(78 %)
22 diff
(97.4 %id)
BG388306 embryonal carcinoma, cell line, testis ANKRD27.a 3941 to 4458 24 to 539   AAA   516/539
(95 %)
6 diff
(98.9 %id)
BG390814 embryonal carcinoma, cell line, testis ANKRD27.a 2599 to 3395 1 to 795       795/801
(99 %)
29 diff
(96.4 %id)
BG392362 embryonal carcinoma, cell line, testis ANKRD27.a 1530 to 2331 1 to 802       802/916
(87 %)
8 diff
(99.2 %id)
BG339692 leiomyosarcoma cell line, uterus ANKRD27.a 3304 to 4095 1 to 797       797/799
(99 %)
13 diff
(98.4 %id)
BG324404 Kidney, renal cell adenocarcinoma ANKRD27.a 1080 to 1859 1 to 783       783/904
(86 %)
25 diff
(97.3 %id)
BG475335 melanotic melanoma, skin ANKRD27.a 3535 to 4409 1 to 876       876/876
(100 %)
17 diff
(98.1 %id)
BG475542 melanotic melanoma, skin ANKRD27.a 3535 to 4457 1 to 927       927/941
(98 %)
31 diff
(96.8 %id)
BG577070 breast, mammary adenocarcinoma, cell line ANKRD27.a 3748 to 4455 1 to 710   AAA   710/710
(100 %)
3 diff
(99.6 %id)
BG719163 testis ANKRD27.a 26 to 754 6 to 737       732/737
(99 %)
13 diff
(98.3 %id)
BG828110 muscle, rhabdomyosarcoma ANKRD27.h 1 to 833 1 to 843   tiling clone,   843/844
(99 %)
23 diff
(97.3 %id)
BI256403 cervical carcinoma cell line, cervix ANKRD27.a 3737 to 4446 1 to 712       712/733
(97 %)
4 diff
(99.5 %id)
BI757039 brain ANKRD27.a 2674 to 3413 1 to 744       744/744
(100 %)
9 diff
(98.8 %id)
BI523701 pooled lung and spleen ANKRD27.a 2773 to 3470 1 to 699       699/733
(95 %)
10 diff
(98.7 %id)
BI524852 pooled lung and spleen ANKRD27.a 3501 to 4412 919 to 1       919/919
(100 %)
24 diff
(97.4 %id)
BI458731 testis ANKRD27.f 1 to 600 6 to 605 N69H tiling clone,   600/605
(99 %)
9 diff
(98.6 %id)
BC045605 testis ANKRD27.a 5 to 4455 1 to 4451 K81* tiling clone, available from MGC, AAA   4451/4451
(100 %)
12 diff
(99.8 %id)
BI462844 testis ANKRD27.a 1 to 702 1 to 707   available from MGC,   707/864
(81 %)
33 diff
(96.2 %id)
BM918209 blood, natural killer cells, cell line ANKRD27.a 1807 to 2627 1 to 827       827/1008
(82 %)
7 diff
(99.4 %id)
BM473365 leiomyosarcoma, uterus ANKRD27.a 3059 to 3766 1 to 710       710/1182
(60 %)
15 diff
(98.8 %id)
BM042250.
matches multiple genes
melanotic melanoma, cell line, skin ANKRD27.a 267 to 691 1 to 430     also hits gene DHRS11 430/691
(62 %)
9 diff
(98.7 %id)
BM456760 embryonal carcinoma, cell line, testis ANKRD27.a 88 to 1052 1 to 972       972/1042
(93 %)
21 diff
(98.0 %id)
BQ269341 Pancreas, Purified pancreatic islet ANKRD27.i-u 1 to 589 1 to 589 exact tiling clone,   589/589
(100 %)
3 diff
(99.5 %id)
BQ285983 Pancreas, Purified pancreatic islet ANKRD27.a 3866 to 4455 595 to 8       588/595
(98 %)
0 diff
(100 %id)
BQ276942 mixed (pool of 40 RNAs) ANKRD27.a 3861 to 4451 1 to 589       589/599
(98 %)
9 diff
(98.5 %id)
BQ015367 Chondrosarcoma, Left Pubic Bone ANKRD27.a 3716 to 4460 763 to 19   AAA   745/745
(100 %)
1 diff
(99.9 %id)
BQ218533 epithelioid carcinoma, Pancreas ANKRD27.a 1357 to 1704 1 to 348       348/1065
(32 %)
6 diff
(99.5 %id)
BQ214535 embryonal carcinoma, cell line, testis ANKRD27.a 3016 to 3938 1 to 936       936/1074
(87 %)
34 diff
(96.9 %id)
BQ220451 embryonal carcinoma, cell line, testis ANKRD27.a 56 to 817 1 to 768       768/966
(79 %)
9 diff
(99.1 %id)
BU153844 epithelioid carcinoma, Pancreas ANKRD27.a 3693 to 4456 1 to 766       766/771
(99 %)
3 diff
(99.7 %id)
BQ440443 melanotic melanoma, skin ANKRD27.a 71 to 921 1 to 852       852/867
(98 %)
9 diff
(99.0 %id)
BQ425621 melanotic melanoma, skin ANKRD27.a 1698 to 2467 1 to 777       777/926
(83 %)
6 diff
(99.4 %id)
BU167120 melanotic melanoma, skin ANKRD27.a 58 to 868 1 to 813       813/824
(98 %)
5 diff
(99.4 %id)
BU163425 melanotic melanoma, cell line, skin ANKRD27.a 2009 to 2797 1 to 791       791/952
(83 %)
18 diff
(98.2 %id)
BQ674606 epidermoid carcinoma, cell line, salivary gland ANKRD27.a 2972 to 3322 1 to 351       351/352
(99 %)
1 diff
(99.8 %id)
BQ957834 carcinoma, cell line, Prostate ANKRD27.a 3344 to 4153 1 to 816       816/992
(82 %)
21 diff
(97.9 %id)
BU539864 adenocarcinoma, cell line, breast ANKRD27.a 2002 to 2870 1 to 877       877/878
(99 %)
15 diff
(98.3 %id)
BU860458 adenocarcinoma, cell line, breast ANKRD27.a 2002 to 2535 1 to 537       537/985
(54 %)
9 diff
(99.1 %id)
CX870496 embryonic stem ANKRD27.a 2891 to 3719 1 to 829       829/829
(100 %)
0 diff
(100 %id)
CD109501 Human Placenta, placenta ANKRD27.a 2 to 496 13 to 513       501/897
(55 %)
26 diff
(97.2 %id)
CB988418 Human Placenta, placenta ANKRD27.a 2 to 739 13 to 750       738/755
(97 %)
7 diff
(99.1 %id)
CB989067 Human Placenta, placenta ANKRD27.a 16 to 528 27 to 545       519/857
(60 %)
20 diff
(97.7 %id)
CD108146 brain, Pituitary ANKRD27.a 3209 to 3948 1 to 741       741/904
(81 %)
4 diff
(99.6 %id)
CD512775 brain, Pituitary ANKRD27.a 3590 to 4366 27 to 806       780/907
(85 %)
4 diff
(99.6 %id)
CD516392 White Matter ANKRD27.a 3597 to 4303 27 to 742       716/929
(77 %)
21 diff
(97.8 %id)
CD642844 Embryonic Stem cells ANKRD27.a 34 to 804 10 to 776       767/786
(97 %)
22 diff
(97.3 %id)
CD642834 Embryonic Stem cells ANKRD27.d 46 to 786 9 to 749   tiling clone,   741/797
(92 %)
13 diff
(98.4 %id)
CD642785 Embryonic Stem cells ANKRD27.a 630 to 1399 11 to 775       765/775
(98 %)
18 diff
(97.7 %id)
CF552747 Pooled muscle (cardiac and skeletal) ANKRD27.a 2818 to 3628 1 to 817       817/848
(96 %)
15 diff
(98.3 %id)
TI_57219904   ANKRD27.a 2666 to 3413 24 to 775       752/775
(97 %)
14 diff
(98.2 %id)
TI_44159323   ANKRD27.a 2772 to 3470 88 to 787       700/821
(85 %)
16 diff
(98.1 %id)
TI_44159324   ANKRD27.a 3501 to 4412 919 to 1       919/919
(100 %)
24 diff
(97.4 %id)
DR423300 eye, Pterygium ANKRD27.a 3922 to 4455 1 to 534   AAA   534/534
(100 %)
6 diff
(98.9 %id)
NM_032139.2   ANKRD27.a 10 to 4468 1 to 4459 exact RefSeq,   4459/4461
(99 %)
5 diff
(99.9 %id)
BP315505 mammary gland ANKRD27.a 24 to 530 1 to 503       503/581
(86 %)
15 diff
(97.5 %id)
DA853626 placenta ANKRD27.a 58 to 634 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
CR975950 T-Lymphocytes ANKRD27.a 1071 to 1809 1 to 739       739/739
(100 %)
5 diff
(99.4 %id)
TI_1948235915   ANKRD27.a 1603 to 2539 156 to 1089   AAA   934/1380
(67 %)
26 diff
(98.2 %id)
TI_1948235916   ANKRD27.a 1603 to 2544 148 to 1090       943/1321
(71 %)
20 diff
(98.5 %id)
TI_1948235917   ANKRD27.a 2395 to 3317 1042 to 127       916/1356
(67 %)
22 diff
(98.4 %id)
TI_1948235918   ANKRD27.a 2536 to 3317 910 to 129       782/1288
(60 %)
8 diff
(99.4 %id)
TI_1948236148   ANKRD27.a 1603 to 2511 155 to 1057   AAA   903/1353
(66 %)
20 diff
(98.6 %id)
TI_1948236149   ANKRD27.a 1603 to 2667 145 to 1208       1064/1318
(80 %)
40 diff
(97.0 %id)
TI_1948236150   ANKRD27.a 2345 to 3317 1084 to 130       955/1316
(72 %)
21 diff
(98.5 %id)
TI_1948236151   ANKRD27.a 2537 to 3317 923 to 138       786/1269
(61 %)
19 diff
(98.6 %id)
TI_1948236153   ANKRD27.a 2818 to 3317 624 to 125       500/1386
(36 %)
18 diff
(98.8 %id)
TI_1948236386   ANKRD27.a 1606 to 2495 167 to 1057   fully sequenced, AAA   891/1057
(84 %)
17 diff
(98.4 %id)
TI_1948236387   ANKRD27.a 2465 to 3317 975 to 127   fully sequenced,   750/876
(85 %)
32 diff
(96.4 %id)
DR002998 fetal brain ANKRD27.a 10 to 750 1 to 741       741/742
(99 %)
5 diff
(99.4 %id)
TI_149286310   ANKRD27.a 3691 to 4455 857 to 92   AAA   766/1157
(66 %)
22 diff
(98.1 %id)
TI_149300783   ANKRD27.a 3609 to 4462 927 to 86   AAA   842/965
(87 %)
13 diff
(98.7 %id)
TI_149306805   ANKRD27.a 3765 to 4455 786 to 98   AAA   689/919
(74 %)
8 diff
(99.2 %id)
TI_153987951   ANKRD27.a 4042 to 4456 507 to 92   AAA   416/416
(100 %)
15 diff
(96.4 %id)
TI_154110425   ANKRD27.a 3683 to 4455 826 to 56   AAA   771/940
(82 %)
5 diff
(99.5 %id)
TI_154126412   ANKRD27.a 3676 to 4456 888 to 121   AAA   768/918
(83 %)
48 diff
(94.8 %id)
TI_154134022   ANKRD27.a 3990 to 4455 581 to 112   AAA   470/1337
(35 %)
13 diff
(99.1 %id)
TI_154134043   ANKRD27.a 4020 to 4455 540 to 104   AAA   437/1148
(38 %)
4 diff
(99.7 %id)
TI_154134439   ANKRD27.a 3972 to 4456 585 to 99       487/822
(59 %)
0 diff
(100 %id)
TI_154135700   ANKRD27.a 3850 to 4462 707 to 91   AAA   617/960
(64 %)
9 diff
(99.1 %id)
TI_154136967   ANKRD27.a 3692 to 4463 869 to 95   AAA   775/1157
(66 %)
25 diff
(97.9 %id)
TI_154138585   ANKRD27.a 2933 to 3439 82 to 588       507/508
(99 %)
2 diff
(99.7 %id)
TI_154138621   ANKRD27.a 2932 to 3437 81 to 589       509/510
(99 %)
21 diff
(95.9 %id)
TI_154149184   ANKRD27.a 59 to 671 66 to 679       614/706
(86 %)
58 diff
(91.8 %id)
TI_154149197   ANKRD27.a 1660 to 2339 71 to 746       676/709
(95 %)
20 diff
(97.2 %id)
TI_154149351   ANKRD27.a 209 to 913 77 to 783       707/849
(83 %)
16 diff
(98.2 %id)
TI_154150414   ANKRD27.a 1163 to 1885 82 to 805       724/728
(99 %)
17 diff
(97.7 %id)
TI_154153305   ANKRD27.a 209 to 802 80 to 673       594/609
(97 %)
11 diff
(98.2 %id)
TI_154153908   ANKRD27.a 613 to 1262 84 to 732       649/649
(100 %)
10 diff
(98.5 %id)
TI_154153964   ANKRD27.a 613 to 1268 84 to 739       656/656
(100 %)
3 diff
(99.6 %id)
TI_154154761   ANKRD27.a 69 to 690 80 to 700       621/639
(97 %)
13 diff
(98.0 %id)
TI_154155002   ANKRD27.b 8 to 658 90 to 740   tiling clone,   651/651
(100 %)
4 diff
(99.4 %id)
TI_154157810   ANKRD27.a 186 to 754 93 to 659       567/661
(85 %)
15 diff
(97.8 %id)
TI_154157851   ANKRD27.a 186 to 812 91 to 717       627/669
(93 %)
12 diff
(98.3 %id)
TI_154165707   ANKRD27.a 53 to 522 80 to 549       470/471
(99 %)
1 diff
(99.8 %id)
TI_154173127   ANKRD27.a 186 to 690 80 to 584       505/617
(81 %)
34 diff
(94.5 %id)
TI_154174096   ANKRD27.a 186 to 660 81 to 562       482/691
(69 %)
24 diff
(96.6 %id)
TI_154174441   ANKRD27.a 186 to 754 90 to 661       570/616
(92 %)
31 diff
(95.0 %id)
BU686618 lung, Primary Lung Epithelial Cells ANKRD27.a 3765 to 4455 707 to 19   AAA   689/703
(98 %)
8 diff
(98.9 %id)
BM971921 lung ANKRD27.a 3875 to 4455 600 to 19   AAA   582/582
(100 %)
2 diff
(99.7 %id)
BM976786 lung, Primary Lung Cystic Fibrosis EpithelialCells ANKRD27.a 3738 to 4462 741 to 19   AAA   723/723
(100 %)
2 diff
(99.8 %id)
CB241122 Human Lung Epithelial cells, lung ANKRD27.a 3726 to 4455 745 to 19   AAA   727/727
(100 %)
7 diff
(99.1 %id)
CA448155 Chondrosarcoma, Left Pubic Bone ANKRD27.a 3701 to 4455 772 to 19   AAA   754/754
(100 %)
1 diff
(99.9 %id)
BU625291 cell lines, Enchondroma ANKRD27.a 3725 to 4455 749 to 19   AAA   731/731
(100 %)
0 diff
(100 %id)
CD369706 Alveolar Macrophage, lung ANKRD27.a 3959 to 4456 516 to 19   AAA   498/498
(100 %)
0 diff
(100 %id)
BU163425 melanotic melanoma, cell line, skin ANKRD27.a 2009 to 2797 1 to 791       791/952
(83 %)
18 diff
(98.2 %id)
BU163425 melanotic melanoma, cell line, skin ANKRD27.a 2009 to 2797 1 to 791       791/952
(83 %)
18 diff
(98.2 %id)
BQ674606 IMAGE:6255498 ANKRD27.aAug10 3322 351 IMAGE:6255498     351 1
BQ674606 IMAGE:6255498 ANKRD27.aAug10 3322 351 IMAGE:6255498     351 1
BQ957834 IMAGE:6381931 ANKRD27.aAug10 4153 816 IMAGE:6381931     816 21
BQ957834 IMAGE:6381931 ANKRD27.aAug10 4153 816 IMAGE:6381931     816 21
BU539864 IMAGE:6570678 ANKRD27.aAug10 2870 877 IMAGE:6570678     877 15
BU539864 IMAGE:6570678 ANKRD27.aAug10 2870 877 IMAGE:6570678     877 15
BU860458 IMAGE:6651559 ANKRD27.aAug10 2535 537 IMAGE:6651559     537 9
BU860458 IMAGE:6651559 ANKRD27.aAug10 2535 537 IMAGE:6651559     537 9
CX870496 IMAGE:7475266 ANKRD27.aAug10 3719 829 IMAGE:7475266     829 0
CD109501 IMAGE:30341018 ANKRD27.aAug10 496 513 IMAGE:30341018     501 26
CD109501 IMAGE:30341018 ANKRD27.aAug10 496 513 IMAGE:30341018     501 26
CB988418 IMAGE:30342449 ANKRD27.aAug10 739 750 IMAGE:30342449     738 7
CB988418 IMAGE:30342449 ANKRD27.aAug10 739 750 IMAGE:30342449     738 7
CB989067 IMAGE:30345984 ANKRD27.aAug10 528 545 IMAGE:30345984     519 20
CB989067 IMAGE:30345984 ANKRD27.aAug10 528 545 IMAGE:30345984     519 20
CD108146 IMAGE:30368774 ANKRD27.aAug10 3948 741 IMAGE:30368774     741 4
CD108146 IMAGE:30368774 ANKRD27.aAug10 3948 741 IMAGE:30368774     741 4
CD512775 IMAGE:30392223 ANKRD27.aAug10 4366 806 IMAGE:30392223     780 4
CD512775 IMAGE:30392223 ANKRD27.aAug10 4366 806 IMAGE:30392223     780 4
CD516392 IMAGE:30399519 ANKRD27.aAug10 4303 742 IMAGE:30399519     716 21
CD642844 IMAGE:30425834 ANKRD27.aAug10 804 776 IMAGE:30425834     767 22
CD642834 IMAGE:30425882 ANKRD27.dAug10 786 749 IMAGE:30425882     741 13
CD642785 IMAGE:30426839 ANKRD27.aAug10 1399 775 IMAGE:30426839     765 18
CF552747 IMAGE:30529074 ANKRD27.aAug10 3628 817 IMAGE:30529074     817 15
TI_57219904 INCYTE_603028780 ANKRD27.aAug10 3413 775 INCYTE_603028780     752 14
TI_44159323 INCYTE_603051875 ANKRD27.aAug10 3470 787 INCYTE_603051875     700 16
TI_44159324 INCYTE_603051875 ANKRD27.aAug10 4412 1 INCYTE_603051875     919 24
DR423300 nav24c11 ANKRD27.aAug10 4455 534 nav24c11     534 6
DR423300 nav24c11 ANKRD27.aAug10 4455 534 nav24c11     534 6
NM_032139.2 NM_032139 ANKRD27.aAug10 4468 4459 NM_032139     4459 5
BP315505 OFR08730 ANKRD27.aAug10 530 503 OFR08730     503 15
DA853626 PLACE7003889 ANKRD27.aAug10 634 579 PLACE7003889     578 1
CR975950 RZPDp9016P247 ANKRD27.aAug10 1809 739 RZPDp9016P247     739 5
TI_1948235915 SC_31036_2_E5 ANKRD27.aAug10 2539 1089 SC_31036_2_E5     934 26
TI_1948235916 SC_31036_2_E5__1 ANKRD27.aAug10 2544 1090 SC_31036_2_E5__1     943 20
TI_1948235917 SC_31036_2_E5__2 ANKRD27.aAug10 3317 127 SC_31036_2_E5__2     916 22
TI_1948235918 SC_31036_2_E5__3 ANKRD27.aAug10 3317 129 SC_31036_2_E5__3     782 8
TI_1948236148 SC_31036_3_E5 ANKRD27.aAug10 2511 1057 SC_31036_3_E5     903 20
TI_1948236149 SC_31036_3_E5__1 ANKRD27.aAug10 2667 1208 SC_31036_3_E5__1     1064 40
TI_1948236150 SC_31036_3_E5__2 ANKRD27.aAug10 3317 130 SC_31036_3_E5__2     955 21
TI_1948236151 SC_31036_3_E5__3 ANKRD27.aAug10 3317 138 SC_31036_3_E5__3     786 19
TI_1948236153 SC_31036_3_E6__1 ANKRD27.aAug10 3317 125 SC_31036_3_E6__1     500 18
TI_1948236386 SC_31036_4_E5 ANKRD27.aAug10 2495 1057 SC_31036_4_E5     891 17
TI_1948236387 SC_31036_4_E5 ANKRD27.aAug10 3317 127 SC_31036_4_E5     750 32
DR002998 TC105947 ANKRD27.aAug10 750 741 TC105947     741 5
TI_149286310 TI_149286310 ANKRD27.aAug10 4455 92 TI_149286310     766 22
TI_149300783 TI_149300783 ANKRD27.aAug10 4462 86 TI_149300783     842 13
TI_149306805 TI_149306805 ANKRD27.aAug10 4455 98 TI_149306805     689 8
TI_153987951 TI_153987951 ANKRD27.aAug10 4456 92 TI_153987951     416 15
TI_154110425 TI_154110425 ANKRD27.aAug10 4455 56 TI_154110425     771 5
TI_154126412 TI_154126412 ANKRD27.aAug10 4456 121 TI_154126412     768 48
TI_154134022 TI_154134022 ANKRD27.aAug10 4455 112 TI_154134022     470 13
TI_154134043 TI_154134043 ANKRD27.aAug10 4455 104 TI_154134043     437 4
TI_154134439 TI_154134439 ANKRD27.aAug10 4456 99 TI_154134439     487 0
TI_154135700 TI_154135700 ANKRD27.aAug10 4462 91 TI_154135700     617 9
TI_154136967 TI_154136967 ANKRD27.aAug10 4463 95 TI_154136967     775 25
TI_154138585 TI_154138585 ANKRD27.aAug10 3439 588 TI_154138585     507 2
TI_154138621 TI_154138621 ANKRD27.aAug10 3437 589 TI_154138621     509 21
TI_154149184 TI_154149184 ANKRD27.aAug10 671 679 TI_154149184     614 58
TI_154149197 TI_154149197 ANKRD27.aAug10 2339 746 TI_154149197     676 20
TI_154149351 TI_154149351 ANKRD27.aAug10 913 783 TI_154149351     707 16
TI_154150414 TI_154150414 ANKRD27.aAug10 1885 805 TI_154150414     724 17
TI_154153305 TI_154153305 ANKRD27.aAug10 802 673 TI_154153305     594 11
TI_154153908 TI_154153908 ANKRD27.aAug10 1262 732 TI_154153908     649 10
TI_154153964 TI_154153964 ANKRD27.aAug10 1268 739 TI_154153964     656 3
TI_154154761 TI_154154761 ANKRD27.aAug10 690 700 TI_154154761     621 13
TI_154155002 TI_154155002 ANKRD27.bAug10 658 740 TI_154155002     651 4
TI_154157810 TI_154157810 ANKRD27.aAug10 754 659 TI_154157810     567 15
TI_154157851 TI_154157851 ANKRD27.aAug10 812 717 TI_154157851     627 12
TI_154165707 TI_154165707 ANKRD27.aAug10 522 549 TI_154165707     470 1
TI_154173127 TI_154173127 ANKRD27.aAug10 690 584 TI_154173127     505 34
TI_154174096 TI_154174096 ANKRD27.aAug10 660 562 TI_154174096     482 24
TI_154174441 TI_154174441 ANKRD27.aAug10 754 661 TI_154174441     570 31
BU686618 UI-CF-DU1-adp-c-04-0-UI ANKRD27.aAug10 4455 19 UI-CF-DU1-adp-c-04-0-UI     689 8
BU686618 UI-CF-DU1-adp-c-04-0-UI ANKRD27.aAug10 4455 19 UI-CF-DU1-adp-c-04-0-UI     689 8
BM971921 UI-CF-EC1-abo-b-17-0-UI ANKRD27.aAug10 4455 19 UI-CF-EC1-abo-b-17-0-UI     582 2
BM976786 UI-CF-EN1-adb-g-08-0-UI ANKRD27.aAug10 4462 19 UI-CF-EN1-adb-g-08-0-UI     723 2
BM976786 UI-CF-EN1-adb-g-08-0-UI ANKRD27.aAug10 4462 19 UI-CF-EN1-adb-g-08-0-UI     723 2
CB241122 UI-CF-FN0-afv-h-03-0-UI ANKRD27.aAug10 4455 19 UI-CF-FN0-afv-h-03-0-UI     727 7
CB241122 UI-CF-FN0-afv-h-03-0-UI ANKRD27.aAug10 4455 19 UI-CF-FN0-afv-h-03-0-UI     727 7
CA448155 UI-H-ED1-ayj-i-04-0-UI ANKRD27.aAug10 4455 19 UI-H-ED1-ayj-i-04-0-UI     754 1
CA448155 UI-H-ED1-ayj-i-04-0-UI ANKRD27.aAug10 4455 19 UI-H-ED1-ayj-i-04-0-UI     754 1
BU625291 UI-H-FG1-bgm-b-12-0-UI ANKRD27.aAug10 4455 19 UI-H-FG1-bgm-b-12-0-UI     731 0
BU625291 UI-H-FG1-bgm-b-12-0-UI ANKRD27.aAug10 4455 19 UI-H-FG1-bgm-b-12-0-UI     731 0
CD369706 UI-H-FT1-bkd-n-14-0-UI ANKRD27.aAug10 4456 19 UI-H-FT1-bkd-n-14-0-UI     498 0
CD369706 UI-H-FT1-bkd-n-14-0-UI ANKRD27.aAug10 4456 19 UI-H-FT1-bkd-n-14-0-UI     498 0
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI